Both pills launched at $149 per month for self-pay patients, a fraction of the cost of injectable GLP-1s, which have typically run upwards of $1,000 per month
It also restrains the movement of glucose to enter the body cells
Common Food Sources of L-Carnitine: Beef: Approximately 80 to 90 mg per 100 grams Pork: Around 25 to 30 mg per 100 grams Fish: Roughly 5 to 10 mg per 100 grams Chicken: About 3 to 5 mg per 100 grams Milk and Dairy: Around 2 to 3 mg per 100 ml Individuals who follow vegetarian or vegan diets often have lower L-carnitine levels because plant-based foods contain very little of it
FEM: Writing review and editing, Validation

Current Research Status and Future Directions Where We Are Now (2026) Retatrutide is currently in Phase 3 clinical development under Eli Lilly's TRIUMPH program, which includes multiple trials: TRIUMPH-3 Obesity without type 2 diabetes Evaluating 12mg vs 9mg vs placebo in adults with BMI 30 or 27 with comorbidities TRIUMPH-4 Obesity with type 2 diabetes Testing efficacy and safety in patients with both conditions (preliminary: 28.7% weight loss) MASLD/NASH Trials Metabolic dysfunction-associated steatotic liver disease Leveraging glucagon's liver fat reduction effects Cardiovascular Outcomes Long-term CV safety and benefits Following precedent of STEP and SURMOUNT trials for GLP-1 drugs Timeline to FDA Approval 2023: Phase 2 results published (NEJM) 2024-2026: Phase 3 trials ongoing (TRIUMPH program) 2026-2027: Anticipated FDA submission (if trials successful) 2027-2028: Potential FDA approval and commercial launch What Researchers Are Watching The main questions Phase 3 needs to answer: Long-term efficacy: Does weight loss plateau or continue beyond 48 weeks

Here is what healthcare providers need to know about injectable L-Carnitine and whether it may be appropriate to offer in their practice